MO-ASM-GLOBAL
23.5.2024 18:01:32 CEST | Business Wire | Press release
Bass Pro Shops Big Cedar Lodge announced today that on July 21 the Ozarks will rock as the ancient hills, valleys and lakes never have when the world’s greatest rock-and-roll band, The Rolling Stones, light up Thunder Ridge Nature Arena for the last performance on their final North American tour.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523211894/en/
Rendering of Thunder Ridge Nature Arena (Graphic: Business Wire)
The concert promises to be one of the most memorable and highly anticipated concert events ever. It is a pairing of the World’s Greatest Rock-and-Roll Band and the most breathtaking and awe-inspiring outdoor amphitheater in all of North America.
The Thunder Ridge concert stop is part of the “Hackney Diamonds Tour ’24” for The Rolling Stones, which includes 20 performances in 16 cities. Tickets will go on sale Friday, May 31, and will be available at ThunderRidgeNatureArena.com.
“We’re honored to host The Rolling Stones at Thunder Ridge Nature Arena and to showcase the amazing beauty of the Ozarks to music fans of all generations,” said Johnny Morris, visionary conservationist and founder of Bass Pro Shops. “The Stones are the most iconic rock-and-roll band ever, and we know they will put on a remarkable show that no one will ever forget! Their appearance will become a part of the history of this beautiful mountain in the Ozarks.”
Thunder Ridge is a world-class destination admired by legends of rock.
Representatives from The Rolling Stones scouted Thunder Ridge by attending the sold-out Garth Brooks concert in September 2022. After attending the show, the advance team reported back that Thunder Ridge was one of the most extraordinary and beautiful event venues they had ever seen.
A legendary night of entertainment began on a fishing trip with two of the leading conservationists of our time.
A partnership between The Rolling Stones, the Ozarks and Johnny Morris is something few would have expected; but, in fact, this is a relationship decades in the making. More than 20 years ago, the Stones renowned keyboard and piano player, Chuck Leavell, joined Johnny Morris to celebrate the opening of a Bass Pro Shops near Chuck’s home in Macon, Georgia. Out of this shared experience, Johnny and Chuck developed a special friendship founded on conservation, a love of the outdoors and a few remarkable shared fishing adventures. And now their adventure continues with a concert unlike anything that has ever been seen in the Ozarks.
A noted conservationist, Chuck Leavell is one of only three recipients of an Honorary Forest Ranger award from the U.S. Forest Service and is also a past recipient of the National Outstanding Tree Farmer award. Johnny Morris, is also a legend in conservation and is a recipient of the prestigious Audubon Medal, considered by many to be the highest award in conservation. In the 114-year history of Audubon there have been only 57 recipients for this prestigious award.
Awe-inspiring, nature-based entertainment venue.
The Rolling Stones concert at Thunder Ridge Nature Arena underscores Johnny’s commitment to create one of the finest outdoor entertainment venues in North America and shares the beauty of his beloved Ozarks with others for generations to come. It’s more than just a place for spectacular concerts, rodeos and conventions. The property has been placed in a not-for-profit foundation, and all proceeds from events at the arena will go to further enhance the facilities and support conservation.
Located on about 1,200 acres near Ridgedale, Thunder Ridge is adjacent to the Bass Pro Shops Big Cedar Lodge on land originally purchased by Johnny Morris about 30 years ago. For the past decade, it has accommodated large gatherings, including concerts by Garth Brooks, Hank Williams Jr., Chris Janson, Dierks Bentley, Tracy Lawrence and other major acts.
It also has hosted air shows, hot air balloon shows, the U.S. Open Bowfishing Championship, the U.S. Open National Bass Tournament, the National 4-H Youth Council, rodeos, conventions, symposiums and special events and is set to host nature-based activities for all ages and interests for years to come.
Thunder Ridge is the latest jewel in Big Cedar Lodge’s proud tradition of hosting world-class hospitality and entertainment experiences that span a variety of recreational markets.
The vision for the future is to continue to host a wide variety of world-class outdoor events. The Rolling Stones performance is only the latest in a summer full of marquee concerts already announced for Thunder Ridge. This lineup includes:
- May 25 – Morgan Wallen
- June 13 – Chris Stapleton
- June 15 – Fuerza Regida
- July 21 – The Rolling Stones
- July 27 – Luke Bryan
- Aug. 31 – Slightly Stoopid & Dirty Heads w / HIRIE
- Sept. 8 – Imagine Dragons
- Sept. 21 – Pitbull
More than six decades of rock-and-roll royalty.
Over the last 60 years, The Rolling Stones have defined the rock-and-roll movement, led by vocalist Mick Jagger and guitarist Keith Richards. The group has estimated album sales of 250 million, making them one of the best-selling musical artists of all time.
The Stones have released 30 studio albums, 23 live albums and 12 official compilation albums; and CNN has called them “far and away the most successful act in rock today.” The Grammy Award-winning band was inducted into the Rock & Roll Hall of Fame in 1989 and the U.K. Music Hall of Fame in 2004 and have been ranked by music-industry watchdogs Billboard magazine and Rolling Stone magazine as one of the greatest bands of all time.
This tour is in support of their widely heralded Hackney Diamonds album release from 2022, which received rave reviews from fans and music critics everywhere.
About Thunder Ridge Nature Arena
Thunder Ridge Nature Arena is a breathtaking outdoor amphitheater nestled in the heart of the Ozarks in Ridgedale, Missouri, just a few miles south of Branson. Situated on over 1,200 acres of land dedicated to conservation, the venue offers stunning views of Table Rock Lake and the Boston Mountains of Arkansas. Thunder Ridge Nature Arena is part of the Johnny Morris Conservation Foundation, dedicated to preserving and celebrating the natural beauty of the Ozarks. All venue proceeds go directly to conservation efforts to protect the land, wildlife and natural habitats of the Ozark region.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240523211894/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom